JNJ-61186372, JNJ-63723283, JNJ-63723283
61186372PANSC2002
Phase 2 small_molecule active
Quick answer
JNJ-61186372, JNJ-63723283, JNJ-63723283 for Metastatic Non-small Cell Lung Cancer is a Phase 2 program (small_molecule) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janssen-Cilag International N.V.
- Indication
- Metastatic Non-small Cell Lung Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active